XML 74 R56.htm IDEA: XBRL DOCUMENT
v3.23.4

STOCKHOLDERS EQUITY (Details Narrative) - USD ($) |  | 1 Months Ended | 12 Months Ended
--- | --- | --- | ---
May 02, 2023 | Jul. 20, 2023 | Sep. 30, 2023 | Sep. 30, 2022
Common stock shares issued | 913,234 | 2,500,000 | 47,422,304 | 43,448,317
Aggregate net proceeds | $ 1,550,000 | $ 5,000,000.0 |  |
Public offering price per share | $ 1.70 | $ 2.00 |  |
Proceeds from issuance of warrant |  |  | $ 40,000 | $ 10,000
Warrants exercised |  |  | 217,752 | 25,205
Ergomed [Member] |  |  |  |
Prepaid of resold amount |  |  | $ 0 | $ 22,000

X
- References No definition available. + Details
Name: | cvm_AggregateNetProceedsFromSaleOfSecurities
Namespace Prefix: | cvm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_PrepaidAmountOfResold
Namespace Prefix: | cvm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | cvm_ProceedFromIssuanceOrSaleOfEquity
Namespace Prefix: | cvm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of non-option equity instruments exercised by participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_PlanNameAxis=cvm_ErgomedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |